Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/28180
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-08-12T07:51:24Z | - |
dc.date.available | 2022-08-12T07:51:24Z | - |
dc.date.issued | 2003 | - |
dc.identifier.citation | Gemici, K. vd. (2003). “Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial Doppler ultrasonography during hypertensive crisis”. Blood Pressure, 12(1), 46-48. | en_US |
dc.identifier.issn | 1651-1999 | - |
dc.identifier.uri | https://doi.org/10.1080/08037050310000454 | - |
dc.identifier.uri | http://hdl.handle.net/11452/28180 | - |
dc.description.abstract | Objective: This study was designed to show the effects of sublingually administered nifedipine and captopril on middle cerebral arterial blood flow during hypertensive crisis in the emergency department. Methods and results: Transcranial Doppler ultrasonography (TCD) was performed on the patients fulfilling the criteria (15 patients given captopril, 13 patients given nifedipine, mean (+/-SD) age 56 +/- 11 and 54 +/- 10 years, respectively). Then, patients were randomized into sublingually administered captopril or nifedipine groups and after the drug administration, TCD was repeated. Initial systolic and diastolic blood pressures were 200 +/- 21/125 +/- 21 mmHg in the captopril group and 199 +/- 17/123 +/- 20 mmHg in the nifedipine group. There was no significant difference between antihypertensive effects of the drugs after initiation of treatment. Before the treatment with captopril, middle cerebral artery (MCA) flow velocities (Vm) and pulsatility index (PI) were 76.74 +/- 6.38 cm/s and 1.18 +/- 0.09, respectively. The values after the treatment with captopril were 78.21 +/- 15.24 cm/s (p < 0.05) and 0.92 +/- 0.08 (p < 0.001), respectively. Before the treatment with nifedipine, Vm and PIS were 64.73 +/- 5.11 cm/s and 1.14 +/- 0.18, respectively. After the treatment with nifedipine, Vm was 60.04 +/- 5.36 cm/s (p < 0.01) and PI was 1.21 +/- 0.09 (p < 0.01). Conclusion: After treatment with captopril, PIs were decreased to normal limits but in the group treated with nifedipine, PIs increased to more pathological values. These results showed that we should reconsider the use of nifedipine in the emergency departments as an antihypertensive agent in hypertensive attack treatment. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor and Francis | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cardiovascular system and cardiology | en_US |
dc.subject | Hypertensive crisis | en_US |
dc.subject | Pulsatility index | en_US |
dc.subject | Sublingual captopril | en_US |
dc.subject | Sublingual nifedipine | en_US |
dc.subject | Transcranial doppler ultrasonography | en_US |
dc.subject | Cerebral-blood-flow | en_US |
dc.subject.mesh | Administration, sublingual | en_US |
dc.subject.mesh | Analysis of variance | en_US |
dc.subject.mesh | Antihypertensive agents | en_US |
dc.subject.mesh | Blood flow velocity | en_US |
dc.subject.mesh | Blood pressure | en_US |
dc.subject.mesh | Calcium channel blockers | en_US |
dc.subject.mesh | Captopril | en_US |
dc.subject.mesh | Cerebral arteries | en_US |
dc.subject.mesh | Diastole | en_US |
dc.subject.mesh | Double-blind method | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypertension | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Nifedipine | en_US |
dc.subject.mesh | Prospective studies | en_US |
dc.subject.mesh | Pulsatile flow | en_US |
dc.subject.mesh | Systole | en_US |
dc.subject.mesh | Time factors | en_US |
dc.subject.mesh | Treatment outcome | en_US |
dc.subject.mesh | Ultrasonography, doppler, transcranial | en_US |
dc.title | Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial Doppler ultrasonography during hypertensive crisis | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000182107500009 | tr_TR |
dc.identifier.scopus | 2-s2.0-0037257382 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Kardiyoloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Acil Tıp Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-7528-3557 | tr_TR |
dc.identifier.startpage | 46 | tr_TR |
dc.identifier.endpage | 48 | tr_TR |
dc.identifier.volume | 12 | tr_TR |
dc.identifier.issue | 1 | tr_TR |
dc.relation.journal | Blood Pressure | en_US |
dc.contributor.buuauthor | Gemici, Kani | - |
dc.contributor.buuauthor | Baran, İbrahim | - |
dc.contributor.buuauthor | Bakar, Mustafa | - |
dc.contributor.buuauthor | Demircan, Celalettin | - |
dc.contributor.buuauthor | Özdemir, Bülent | - |
dc.contributor.buuauthor | Cordan, Jale | - |
dc.contributor.researcherid | P-5653-2014 | tr_TR |
dc.contributor.researcherid | X-8540-2019 | tr_TR |
dc.identifier.pubmed | 12699135 | tr_TR |
dc.subject.wos | Peripheral vascular disease | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 6602927677 | tr_TR |
dc.contributor.scopusid | 35572557400 | tr_TR |
dc.contributor.scopusid | 26643051200 | tr_TR |
dc.contributor.scopusid | 6507741676 | tr_TR |
dc.contributor.scopusid | 7004168959 | tr_TR |
dc.contributor.scopusid | 6602518666 | tr_TR |
dc.subject.scopus | Clevidipine; Labetalol; Antihypertensive Agent | en_US |
dc.subject.emtree | Antihypertensive agent | en_US |
dc.subject.emtree | Captopril | en_US |
dc.subject.emtree | Clonidine | en_US |
dc.subject.emtree | Labetalol | en_US |
dc.subject.emtree | Nifedipine | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Artery blood flow | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Blood pressure measurement | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Clinical trial | en_US |
dc.subject.emtree | Controlled clinical trial | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Diastolic blood pressure | en_US |
dc.subject.emtree | Doppler echography | en_US |
dc.subject.emtree | Double blind procedure | en_US |
dc.subject.emtree | Drug effect | en_US |
dc.subject.emtree | Emergency ward | en_US |
dc.subject.emtree | Flow rate | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Hypertensive crisis | en_US |
dc.subject.emtree | Middle cerebral artery | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Pulsatile flow | en_US |
dc.subject.emtree | Randomized controlled trial | en_US |
dc.subject.emtree | Statistical analysis | en_US |
dc.subject.emtree | Systolic blood pressure | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.